|
Bagdy, G., & Kalogeras, K. T. (1993). Stimulation of 5-HT1A and 5-HT2/5-HT1C receptors induce oxytocin release in the male rat. Brain Res, 611(2), 330-332. Camerino, C. (2009). Low sympathetic tone and obese phenotype in oxytocin-deficient mice. Obesity (Silver Spring), 17(5), 980-984. Chen, F. S., Kumsta, R., von Dawans, B., Monakhov, M., Ebstein, R. P., & Heinrichs, M. (2011). Common oxytocin receptor gene (OXTR) polymorphism and social support interact to reduce stress in humans. Proc Natl Acad Sci U S A, 108(50), 19937-19942. Chen, Y. C., Shen, Y. C., Hung, Y. J., Chou, C. H., Yeh, C. B., & Perng, C. H. (2007). Comparisons of glucose-insulin homeostasis following maprotiline and fluoxetine treatment in depressed males. J Affect Disord, 103(1-3), 257-261. Costa, B., Pini, S., Gabelloni, P., Abelli, M., Lari, L., Cardini, A., . . . Martini, C. (2009). Oxytocin receptor polymorphisms and adult attachment style in patients with depression. Psychoneuroendocrinology, 34(10), 1506-1514. Davidson, J. R. (2010). Major depressive disorder treatment guidelines in America and Europe. J Clin Psychiatry, 71 Suppl E1, e04. De Long, N. E., Hyslop, J. R., Raha, S., Hardy, D. B., & Holloway, A. C. (2014). Fluoxetine-induced pancreatic beta cell dysfunction: New insight into the benefits of folic acid in the treatment of depression. Journal of Affective Disorders, 166(0), 6-13. Deblon, N., Veyrat-Durebex, C., Bourgoin, L., Caillon, A., Bussier, A. L., Petrosino, S., . . . Rohner-Jeanrenaud, F. (2011). Mechanisms of the anti-obesity effects of oxytocin in diet-induced obese rats. PLoS One, 6(9), e25565. Dunning, B. E., Moltz, J. H., & Fawcett, C. P. (1984). Modulation of insulin and glucagon secretion from the perfused rat pancreas by the neurohypophysial hormones and by desamino-D-arginine vasopressin (DDAVP). Peptides, 5(5), 871-875. Eaton, J. L., Roache, L., Nguyen, K. N., Cushing, B. S., Troyer, E., Papademetriou, E., & Raghanti, M. A. (2012). Organizational effects of oxytocin on serotonin innervation. Dev Psychobiol, 54(1), 92-97. Emiliano, A. B., Cruz, T., Pannoni, V., & Fudge, J. L. (2007). The interface of oxytocin-labeled cells and serotonin transporter-containing fibers in the primate hypothalamus: a substrate for SSRIs therapeutic effects? Neuropsychopharmacology, 32(5), 977-988. Garcia, F. D., Coquerel, Q., Kiive, E., Dechelotte, P., Harro, J., & Fetissov, S. O. (2011). Autoantibodies reacting with vasopressin and oxytocin in relation to cortisol secretion in mild and moderate depression. Prog Neuropsychopharmacol Biol Psychiatry, 35(1), 118-125. Global burden of mental disorders and the need for a comprehensive, coordinated response from health and social sectors at the country level. (2012). http://apps.who.int/gb/ebwha/pdf_files/WHA65/A65_10-en.pdf Heaton RK, C. G., Talley JL, Kay GG, Curtiss G. (1993). Wisconsin Card Sorting Test manual: Revised and expanded.: Odessa, FL: Psychological Assessment Resources. Heinrichs, M., Baumgartner, T., Kirschbaum, C., & Ehlert, U. (2003). Social support and oxytocin interact to suppress cortisol and subjective responses to psychosocial stress. Biol Psychiatry, 54(12), 1389-1398. Jankowski, M., Bissonauth, V., Gao, L., Gangal, M., Wang, D., Danalache, B., . . . Gutkowska, J. (2010). Anti-inflammatory effect of oxytocin in rat myocardial infarction. Basic Res Cardiol, 105(2), 205-218. Jorgensen, H., Kjaer, A., Knigge, U., Moller, M., & Warberg, J. (2003). Serotonin stimulates hypothalamic mRNA expression and local release of neurohypophysial peptides. J Neuroendocrinol, 15(6), 564-571. Kessler, R. C., Berglund, P., Demler, O., Jin, R., Koretz, D., Merikangas, K. R., . . . National Comorbidity Survey, R. (2003). The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R). JAMA, 289(23), 3095-3105. L. Pai, H.-C. W., R.-B. Lu, M.-L. Kuo. (1985). The questionnaire of life stress cognition of adults-revised (full text in Chinese).-. Chinese Journal of Mental Health (Taipei), 3, 195-205. Lawson, E. A., Marengi, D. A., DeSanti, R. L., Holmes, T. M., Schoenfeld, D. A., & Tolley, C. J. (2015). Oxytocin reduces caloric intake in men. Obesity (Silver Spring), 23(5), 950-956. Li, Q., Brownfield, M. S., Battaglia, G., Cabrera, T. M., Levy, A. D., Rittenhouse, P. A., & van de Kar, L. D. (1993). Long-term treatment with the antidepressants fluoxetine and desipramine potentiates endocrine responses to the serotonin agonists 6-chloro-2-[1-piperazinyl]-pyrazine (MK-212) and (+-)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane HCl (DOI). J Pharmacol Exp Ther, 266(2), 836-844. Li, Q., Levy, A. D., Cabrera, T. M., Brownfield, M. S., Battaglia, G., & Van de Kar, L. D. (1993). Long-term fluoxetine, but not desipramine, inhibits the ACTH and oxytocin responses to the 5-HT1A agonist, 8-OH-DPAT, in male rats. Brain Res, 630(1-2), 148-156. Li, Q., Muma, N. A., & van de Kar, L. D. (1996). Chronic fluoxetine induces a gradual desensitization of 5-HT1A receptors: reductions in hypothalamic and midbrain Gi and G(o) proteins and in neuroendocrine responses to a 5-HT1A agonist. J Pharmacol Exp Ther, 279(2), 1035-1042. Maejima, Y., Rita, R. S., Santoso, P., Aoyama, M., Hiraoka, Y., Nishimori, K., . . . Yada, T. (2015). Nasal oxytocin administration reduces food intake without affecting locomotor activity and glycemia with c-Fos induction in limited brain areas. Neuroendocrinology, 101(1), 35-44. Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C. (1985). Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia, 28(7), 412-419. McQuaid, R. J., McInnis, O. A., Abizaid, A., & Anisman, H. (2014). Making room for oxytocin in understanding depression. Neurosci Biobehav Rev, 45, 305-322. Melis, M. R., Succu, S., Sanna, F., Boi, A., & Argiolas, A. (2009). Oxytocin injected into the ventral subiculum or the posteromedial cortical nucleus of the amygdala induces penile erection and increases extracellular dopamine levels in the nucleus accumbens of male rats. Eur J Neurosci, 30(7), 1349-1357. Meynen, G., Unmehopa, U. A., Hofman, M. A., Swaab, D. F., & Hoogendijk, W. J. (2007). Hypothalamic oxytocin mRNA expression and melancholic depression. Mol Psychiatry, 12(2), 118-119. Morton, G. J., Thatcher, B. S., Reidelberger, R. D., Ogimoto, K., Wolden-Hanson, T., Baskin, D. G., . . . Blevins, J. E. (2012). Peripheral oxytocin suppresses food intake and causes weight loss in diet-induced obese rats. Am J Physiol Endocrinol Metab, 302(1), E134-144. Nation, D. A., Szeto, A., Mendez, A. J., Brooks, L. G., Zaias, J., Herderick, E. E., . . . McCabe, P. M. (2010). Oxytocin attenuates atherosclerosis and adipose tissue inflammation in socially isolated ApoE-/- mice. Psychosom Med, 72(4), 376-382. Oliveira-Pelegrin, G. R., Saia, R. S., Carnio, E. C., & Rocha, M. J. (2013). Oxytocin affects nitric oxide and cytokine production by sepsis-sensitized macrophages. Neuroimmunomodulation, 20(2), 65-71. Ozsoy, S., Esel, E., & Kula, M. (2009). Serum oxytocin levels in patients with depression and the effects of gender and antidepressant treatment. Psychiatry Res, 169(3), 249-252. Parker, K. J., Buckmaster, C. L., Schatzberg, A. F., & Lyons, D. M. (2005). Intranasal oxytocin administration attenuates the ACTH stress response in monkeys. Psychoneuroendocrinology, 30(9), 924-929. Parker, K. J., Kenna, H. A., Zeitzer, J. M., Keller, J., Blasey, C. M., Amico, J. A., & Schatzberg, A. F. (2010). Preliminary evidence that plasma oxytocin levels are elevated in major depression. Psychiatry Res, 178(2), 359-362. Purba, J. S., Hoogendijk, W. J., Hofman, M. A., & Swaab, D. F. (1996). Increased number of vasopressin- and oxytocin-expressing neurons in the paraventricular nucleus of the hypothalamus in depression. Arch Gen Psychiatry, 53(2), 137-143. Rahe, C. D. R. R. H. (1975). Epidemiological Studies of Life Change and Illness. The International Journal of Psychiatry in Medicine, 6(1), 133-146. Robinson, K. J., Hazon, N., Lonergan, M., & Pomeroy, P. P. (2014). Validation of an enzyme-linked immunoassay (ELISA) for plasma oxytocin in a novel mammal species reveals potential errors induced by sampling procedure. J Neurosci Methods, 226, 73-79. Roffeei, S. N., Mohamed, Z., Reynolds, G. P., Said, M. A., Hatim, A., Mohamed, E. H., . . . Zainal, N. Z. (2014). Association of FTO, LEPR and MTHFR gene polymorphisms with metabolic syndrome in schizophrenia patients receiving antipsychotics. Pharmacogenomics, 15(4), 477-485. Roh, S. G., Koiwa, K., Sato, K., Ohtani, Y., Takahashi, T., & Katoh, K. (2014). Actions of intravenous injections of AVP and oxytocin on plasma ACTH, GH, insulin and glucagon concentrations in goats. Anim Sci J, 85(3), 286-292. Rush, A. J., Trivedi, M. H., Wisniewski, S. R., Stewart, J. W., Nierenberg, A. A., Thase, M. E., . . . Fava, M. (2006). Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression. N Engl J Med, 354(12), 1231-1242. Rutigliano, G., Rocchetti, M., Paloyelis, Y., Gilleen, J., Sardella, A., Cappucciati, M., . . . Fusar-Poli, P. (2016). Peripheral oxytocin and vasopressin: Biomarkers of psychiatric disorders? A comprehensive systematic review and preliminary meta-analysis. Psychiatry Res, 241, 207-220. Saphire-Bernstein, S., Way, B. M., Kim, H. S., Sherman, D. K., & Taylor, S. E. (2011). Oxytocin receptor gene (OXTR) is related to psychological resources. Proc Natl Acad Sci U S A, 108(37), 15118-15122. Saravani, R., Esmaeeli, E., Kordi Tamendani, M., & Nejad, M. N. (2015). Oxytocin Receptor Gene Polymorphisms in Patients With Diabetes. Gene, Cell and Tissue, 2(2), e27904. Scantamburlo, G., Hansenne, M., Fuchs, S., Pitchot, W., Marechal, P., Pequeux, C., . . . Legros, J. J. (2007). Plasma oxytocin levels and anxiety in patients with major depression. Psychoneuroendocrinology, 32(4), 407-410. Seay, J. S., Lattie, E., Schneiderman, N., Antoni, M. H., Fekete, E. M., Mendez, A. J., . . . Fletcher, M. A. (2014). Linear and Quadratic Associations of Plasma Oxytocin With Depressive Symptoms in Ethnic Minority Women Living With HIV. Journal of Applied Biobehavioral Research, 19(1), 70-78. Shimoyama, I., Ninchoji, T., & Uemura, K. (1990). The finger-tapping test: A quantitative analysis. Archives of Neurology, 47(6), 681-684. Slattery, D. A., & Neumann, I. D. (2010). Oxytocin and Major Depressive Disorder: Experimental and Clinical Evidence for Links to Aetiology and Possible Treatment. Pharmaceuticals, 3(3), 702-724. Smid, H. G., de Witte, M. R., Homminga, I., & van den Bosch, R. J. (2006). Sustained and transient attention in the continuous performance task. J Clin Exp Neuropsychol, 28(6), 859-883. Sokero, T. P., Melartin, T. K., Rytsala, H. J., Leskela, U. S., Lestela-Mielonen, P. S., & Isometsa, E. T. (2003). Suicidal ideation and attempts among psychiatric patients with major depressive disorder. J Clin Psychiatry, 64(9), 1094-1100. Souza-Moreira, L., Campos-Salinas, J., Caro, M., & Gonzalez-Rey, E. (2011). Neuropeptides as pleiotropic modulators of the immune response. Neuroendocrinology, 94(2), 89-100. Stratta, P., Mancini, F., Mattei, P., Daneluzzo, E., Casacchia, M., & Rossi, A. (1997). Association between Striatal Reduction and Poor Wisconsin Card Sorting Test Performance in Patients with Schizophrenia. Biological Psychiatry, 42(9), 816-820. Streiner, D. L. (2014). Statistics commentary series: commentary #3--last observation carried forward. J Clin Psychopharmacol, 34(4), 423-425. Szeto, A., McCabe, P. M., Nation, D. A., Tabak, B. A., Rossetti, M. A., McCullough, M. E., . . . Mendez, A. J. (2011). Evaluation of enzyme immunoassay and radioimmunoassay methods for the measurement of plasma oxytocin. Psychosom Med, 73(5), 393-400. Takayanagi, Y., Kasahara, Y., Onaka, T., Takahashi, N., Kawada, T., & Nishimori, K. (2008). Oxytocin receptor-deficient mice developed late-onset obesity. Neuroreport, 19(9), 951-955. Thompson, S. M., Hammen, C., Starr, L. R., & Najman, J. M. (2014). Oxytocin receptor gene polymorphism (rs53576) moderates the intergenerational transmission of depression. Psychoneuroendocrinology, 43, 11-19. Tost, H., Kolachana, B., Hakimi, S., Lemaitre, H., Verchinski, B. A., Mattay, V. S., . . . Meyer-Lindenberg, A. (2010). A common allele in the oxytocin receptor gene (OXTR) impacts prosocial temperament and human hypothalamic-limbic structure and function. Proc Natl Acad Sci U S A, 107(31), 13936-13941. Uvnas-Moberg, K., Bjokstrand, E., Hillegaart, V., & Ahlenius, S. (1999). Oxytocin as a possible mediator of SSRI-induced antidepressant effects. Psychopharmacology (Berl), 142(1), 95-101. Volkow, N. D., Gur, R. C., Wang, G. J., Fowler, J. S., Moberg, P. J., Ding, Y. S., . . . Logan, J. (1998). Association between decline in brain dopamine activity with age and cognitive and motor impairment in healthy individuals. Am J Psychiatry, 155(3), 344-349. Wang, L., McLeod, H. L., & Weinshilboum, R. M. (2011). Genomics and drug response. N Engl J Med, 364(12), 1144-1153. Watanabe, S., Wei, F. Y., Matsunaga, T., Matsunaga, N., Kaitsuka, T., & Tomizawa, K. (2016). Oxytocin Protects against Stress-Induced Cell Death in Murine Pancreatic beta-Cells. Sci Rep, 6, 25185. Weissman, M. M. (1996). Cross-National Epidemiology of Major Depression and Bipolar Disorder. JAMA: The Journal of the American Medical Association, 276(4), 293. Welch, M. G., Margolis, K. G., Li, Z., & Gershon, M. D. (2014). Oxytocin regulates gastrointestinal motility, inflammation, macromolecular permeability, and mucosal maintenance in mice. Am J Physiol Gastrointest Liver Physiol, 307(8), G848-862. Wu, C. S., Gau, S. S., & Lai, M. S. (2014). Long-term antidepressant use and the risk of type 2 diabetes mellitus: a population-based, nested case-control study in Taiwan. J Clin Psychiatry, 75(1), 31-38; quiz 38. Yao, G., Chung, C. W., Yu, C. F., & Wang, J. D. (2002). Development and verification of validity and reliability of the WHOQOL-BREF Taiwan version. J Formos Med Assoc, 101(5), 342-351. Yegen, B. (2010). Oxytocin and hypothalamo-pituitary adrenal axis. Marmara Pharmaceutcal Journal, 2(14), 61-66. Yoshida, M., Takayanagi, Y., Inoue, K., Kimura, T., Young, L. J., Onaka, T., & Nishimori, K. (2009). Evidence that oxytocin exerts anxiolytic effects via oxytocin receptor expressed in serotonergic neurons in mice. J Neurosci, 29(7), 2259-2271. Yuen, K. W., Garner, J. P., Carson, D. S., Keller, J., Lembke, A., Hyde, S. A., . . . Parker, K. J. (2014). Plasma oxytocin concentrations are lower in depressed vs. healthy control women and are independent of cortisol. J Psychiatr Res, 51(0), 30-36. Zhang, H., Wu, C., Chen, Q., Chen, X., Xu, Z., Wu, J., & Cai, D. (2013). Treatment of obesity and diabetes using oxytocin or analogs in patients and mouse models. PLoS One, 8(5), e61477.
|